Loading company…
Sagent Pharmaceuticals develops, manufactures, and markets generic injectable medicines.
Founded in 2007 and based in Schaumburg, US, Sagent Pharmaceuticals develops and markets generic injectable drugs, including vials, prefilled syringes, and premixed bags. Its products cover critical care, oncology, anesthetics, and anti-infectives. In 2015, it reported revenue of USD 318.30 mn and EBITDA of USD -30.84 mn. Nichi-Iko Pharmaceuticals agreed to acquire Sagent for USD 736 mn in July 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in